Full course description
Infection Prevention Learning Journey
Release Date: 08/01/2024
Expires: 07/31/2025
CID: 62127
The estimated time to complete this enduring material is 75 minutes.
TARGET AUDIENCE
This accredited continuing education activity is intended primarily for healthcare workers and teams which may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.
EDUCATIONAL OBJECTIVES
At the conclusion of this enduring material, the participant should be better able to:
- Describe implementation strategies for effective engineering controls to reduce the transmission of infectious pathogens in healthcare settings.
- Discuss how effective communication between team members can facilitate better infection control practices and how clear instructions and expectations can improve the cleaning and disinfection processes.
- Explain the role of clear, concise communication in training and in real-time situations involving PPE to reduce errors and increase compliance.
ACCREDITED CONTINUING EDUCATION
 |
In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.25 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.
METHOD OF PARTICIPATION
In order to receive continuing education credit, you must complete these steps prior to the activity expiration date.
- View and interact with all lessons in the activity.
- Complete the online evaluation.
- Submit the Completion Attestation.
- The link for receiving your continuing education credits will now be visible.
DISCLOSURE INFORMATION
As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.
DISCLOSURES
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:
FACULTY
The following faculty have nothing to disclose:
Caroline Croyle Persson, MPH, MPA, CPH, CIC
Consultant: APIC Consultant, APIC Text, DCMC Partners
The following faculty have nothing to disclose:
Patricia Ann Tennill, BSN, RN*
*faculty and planning committee member
PLANNING COMMITTEE
Shawn Gibbs, PhD, MBA, CIH
Consultant: Carecubes, Inc.
Angela Hewlett, MD, MS
Consultant: Forecast Orthopedics
Research: Mapp Biopharmaceuticals
The below planning committee members have nothing to disclose:
- Kate Boulter, MPH, BSN
- Sharon Vanairsdale Carrasco, DNP, APRN, ACNC-BC, NP-C, CEN, FAAN
- Britton Clark, MPH
- Valeta Creason-Wahl, MMP
- Chimora Imonugo, MD, MPH
- Heidi Keeler, PhD, MSN/MBA, RN
- Benjamin Mattson, MS Ed
- Jill Morgan, RN
- Jason Noble, BA, BFA
- Renee Paulin, MSN, RN, CWOCN
- Brenda Ram, CMP, CHCP
- Michelle Schwedhelm, MSN, RN, NEA-BC
FINANCIAL SUPPORT
This program is funded by ASPR